BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 2786598)

  • 1. The effect of 12-O-tetradecanoylphorbol-13-acetate (TPA) on leukemic cells from chronic B cell leukemia.
    Tokumine Y; Waki K; Nishimori Y; Kuratsune H; Inoue R; Nakamura Y; Ueda E; Machii T; Kitani T
    Leukemia; 1989 Jul; 3(7):516-21. PubMed ID: 2786598
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of protein tyrosine phosphorylation with B cell differentiation induced by 12-O-tetradecanoylphorbol-13-acetate (TPA).
    Kuratsune H; Owada MK; Tokumine Y; Tagawa S; Nojima J; Shibano M; Nishimori Y; Morita T; Machii T; Kitani T
    Leukemia; 1990 Oct; 4(10):700-3. PubMed ID: 2214873
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phorbol ester induction of plasmacytoid and hairy cell leukemia features in B-type lymphocytic leukemias: the relation to B-cell differentiation and maturation.
    Gazitt Y; Polliack A
    Blood Cells; 1987; 12(2):413-39. PubMed ID: 3497682
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differentiation of purified malignant B cells induced by PMA or by activated normal T cells.
    van Kooten C; Rensink I; Aarden L; van Oers R
    Leukemia; 1993 Oct; 7(10):1576-84. PubMed ID: 8105156
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phenotypic modulation of chronic lymphocytic, prolymphocytic, and lymphoplasmacytic leukemia cells by TPA: induction of TRAP isoenzyme 5 and HD6 (CD22) antigen and enhancement of IgM messenger RNA.
    Thiel E; Pachmann K; Dörken B; Gaedicke G; Ziegler-Heitbrock HW
    Blood Cells; 1987; 12(2):365-83. PubMed ID: 3476168
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phorbol ester (TPA)-induced surface membrane alterations in B-type hairy cell and lymphocytic leukemia cells.
    Polliack A; Gurfel D; Leizerowitz R; Feinstein H; Gazitt Y
    Scan Electron Microsc; 1986; (Pt 4):1523-35. PubMed ID: 3810025
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bryostatin 1-induced hairy cell features on chronic lymphocytic leukemia cells in vitro.
    al-Katib A; Mohammad RM; Dan M; Hussein ME; Akhtar A; Pettit GR; Sensenbrenner LL
    Exp Hematol; 1993 Jan; 21(1):61-5. PubMed ID: 8093352
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immune phenotype and some enzyme patterns in phorbol ester-induced chronic lymphocytic leukemia cells.
    Babusíková O; Mesárosová A; Kusenda J; Koníková E; Klobusická M; Hrivnáková A
    Neoplasma; 1995; 42(5):221-6. PubMed ID: 8552199
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phorbol ester-induced differentiation of chronic B lymphocytic leukaemia cells--regulatory impact of autologous and allogeneic accessory cells.
    Danersund A; Tötterman TH; Nilsson K; Egle-Jansson I; Kabelitz D; Sjöberg O
    Clin Exp Immunol; 1985 Mar; 59(3):644-52. PubMed ID: 3872753
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heterogeneity in TPA-induced differentiation of B-chronic lymphocytic leukemia cells: development of hairy cell or plasmacytoid features are time and dose dependent.
    Gazitt Y; Gurfel D; Leizerowitz R; Feinstein H; Polliack A
    Cancer Invest; 1987; 5(4):309-19. PubMed ID: 3499210
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phenotypic modulation of chronic lymphocytic leukemia cells by phorbol ester: induction of IgM secretion and changes in the expression of B cell-associated surface antigens.
    Gordon J; Mellstedt H; Aman P; Biberfeld P; Klein G
    J Immunol; 1984 Jan; 132(1):541-7. PubMed ID: 6606672
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phorbol ester and B cell-stimulatory factor synergize to induce B-chronic lymphocytic leukemia cells to simultaneous immunoglobulin secretion and DNA synthesis.
    Carlsson M; Matsson P; Rosén A; Sundström C; Tötterman TH; Nilsson K
    Leukemia; 1988 Nov; 2(11):734-44. PubMed ID: 3263557
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lineage relationship of chronic lymphocytic leukemia and hairy cell leukemia: studies with TPA.
    Caligaris-Cappio F; Janossy G; Campana D; Chilosi M; Bergui L; Foà R; Delia D; Giubellino MC; Preda P; Gobbi M
    Leuk Res; 1984; 8(4):567-78. PubMed ID: 6332240
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interleukin-2 enhances the production of tumor necrosis factor-alpha in activated B-type chronic lymphocytic leukemia (B-CLL) cells.
    Larsson LG; Carlsson M; Schena M; Lantz M; Caligaris-Cappio F; Nilsson K
    Leukemia; 1993 Feb; 7(2):226-34. PubMed ID: 8381194
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of selected genes and oncogenes in differentiated HL-60 cells and primary cells from human leukemias.
    Shiosaka T; Tanaka Y
    Anticancer Res; 1989; 9(5):1249-64. PubMed ID: 2589822
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of B-cell chronic lymphocytic leukaemia and hairy cell leukaemia like phenotypes by phorbol ester treatment of normal peripheral blood B-cells.
    Visser L; Poppema S
    Br J Haematol; 1990 Jul; 75(3):359-65. PubMed ID: 2386770
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The immunological profile of B-cell disorders and proposal of a scoring system for the diagnosis of CLL.
    Matutes E; Owusu-Ankomah K; Morilla R; Garcia Marco J; Houlihan A; Que TH; Catovsky D
    Leukemia; 1994 Oct; 8(10):1640-5. PubMed ID: 7523797
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence of phenotypic aberrations in a series of 467 patients with B chronic lymphoproliferative disorders: basis for the design of specific four-color stainings to be used for minimal residual disease investigation.
    Sánchez ML; Almeida J; Vidriales B; López-Berges MC; García-Marcos MA; Moro MJ; Corrales A; Calmuntia MJ; San Miguel JF; Orfao A
    Leukemia; 2002 Aug; 16(8):1460-9. PubMed ID: 12145686
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Soluble interleukin-2 receptor, soluble CD8 and soluble intercellular adhesion molecule-1 levels in hematologic malignancies.
    Srivastava MD; Srivastava A; Srivastava BI
    Leuk Lymphoma; 1994 Jan; 12(3-4):241-51. PubMed ID: 7909467
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD11c (LEU-M5) expression characterizes a B-cell chronic lymphoproliferative disorder with features of both chronic lymphocytic leukemia and hairy cell leukemia.
    Hanson CA; Gribbin TE; Schnitzer B; Schlegelmilch JA; Mitchell BS; Stoolman LM
    Blood; 1990 Dec; 76(11):2360-7. PubMed ID: 1701669
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.